Andy Bowman and Gary Burd have been appointed to senior positions within Caudex Medical
Andy Bowman has been appointed Global Head of Caudex Medical. Andy joins Caudex from the Choice Group where he held the position of CEO of Choice Healthcare Solutions and latterly Vice Chairman of the Choice Group. Andy was instrumental in the global expansion of the Choice medical communications and clinical research business over the past 4 years, particularly in the emerging market regions. Prior to this position, Andy has over 20 years’ pharmaceutical company and agency experience on global and local stages. Having initially qualified as a microbiologist, Andy moved into pharmaceutical sales and then progressed into training, business management and marketing before moving agency-side. During this time, Andy held senior positions in strategic, client service and editorial capacities in advertising, consulting and medical communications agencies.
Caudex Medical has also appointed Gary Burd as Director of Scientific Services, focusing on the development of the Caudex offering and innovation. Gary is joining Caudex from Complete HealthVizion, where he worked for 5 years, initially as an Editorial Team Leader and then a Scientific Director. Prior to this, Gary spent 3 years as an Editorial Projects Manager at Parexel. He brings very strong experience in oncology, rheumatoid arthritis, multiple sclerosis, diabetes, transplantation and inflammation.